Health1 min read

Lilly's next-gen drug outshines Ozempic on weight loss, blood sugar control in trial - Reuters

By · Published by Everything Blog

In short

Eli Lilly's next-generation drug has outperformed Ozempic in a clinical trial, showing superior results in both weight loss and blood sugar control. The findings highlight the potential of Lilly's new treatment within the competitive market for diabetes and weight management therapies.

Key points

  • Eli Lilly's next-generation drug has outperformed Ozempic in a clinical trial, showing su…: Eli Lilly's next-generation drug has outperformed Ozempic in a clinical trial, showing superior results in both weight loss and blood sugar control.
  • The findings highlight the potential of Lilly's new treatment within the competitive mark…: The findings highlight the potential of Lilly's new treatment within the competitive market for diabetes and weight management therapies.

Sources checked by our analysis pipeline: 1

Lilly's next-gen drug outshines Ozempic on weight loss, blood sugar control in trial    Reuters

Original source: news.google.com

Health